Herriot Tabuteau, Chief Executive Officer at Axsome Therapeutics, sold AXSM on Jul 1, 2026
Data as of Oct 16
▼ SELL$11.9M49,666 shares at $240.25Herriot Tabuteau Chief Executive OfficerAXSM Axsome Therapeutics, Inc.
- Traded
- Jul 1, 2026
- Disclosed
- Jul 1, 2026
- Filed
- The same day
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
AXSM since disclosure
−34.7%
after the sale
Similar stocks (XLV) since disclosure
+10.8%
XLV — its sector index fund
Change in closing price from Jul 1, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.